Flexion Therapeutics Inc (FLXN)


Stock Price Forecast

Nov. 18, 2021


Forecasted Returns

7 Days Predict

30 Days Predict

90 Days Predict


Forecasted Market-Excess Returns

7 Days Predict

30 Days Predict

90 Days Predict

Loading Flexion Therapeutics Inc chart...

About the Company

Flexion Therapeutics is a biopharmaceutical company focused on the development and commercialization of novel, local therapies for the treatment of people with musculoskeletal conditions, beginning with osteoarthritis, the most common form of arthritis. The Company's core values are focus, ingenuity, tenacity, transparency and fun.

CEO

Michael Clayman

Exchange

NASDAQ

Website

flexiontherapeutics.com

$100M

Total Revenue

257

Employees

$456M

Market Capitalization

-4.58

Price/Earning ratio

Fundamental Data and Insider Transactions (Quarterly data) Full Screen

Loading the fundamentals chart...

Latest $FLXN News

Pacira (PCRX) Preliminary '23 Revenues Solid, Exparel Strong

2mon ago, source: Zacks.com on MSN

The acquisition of Flexion Therapeutics, Inc. in November 2021 gave Pacira its second marketed product, Zilretta, which is ...

Here's Why You Should Add Pacira (PCRX) Stock to Your Portfolio

10mon ago, source: Hosted on MSN

Product Acquisitions Through Strategic Collaborations, a Positive: In April 2019, Pacira acquired the privately held company, MyoScience, Inc., following ... of Flexion Therapeutics for $8.50 ...

Versant Ventures III, LLC's Net Worth

23d ago, source: Benzinga.com

Inc., and Flexion Therapeutics Inc. Attention insiders: Dive deeper into market movements and stay ahead of the curve with Benzinga Pro! From up-to-the-second news to audio squawks and interactive ...

TRDA Entrada Therapeutics, Inc.

20h ago, source: Seeking Alpha

Entrada Therapeutics, Inc., a clinical-stage biotechnology company, develops endosomal escape vehicle (EEV) therapeutics for the treatment of multiple neuromuscular diseases. Its EEV platform ...

TNGX Tango Therapeutics, Inc.

18h ago, source: Seeking Alpha

Tango Therapeutics, Inc., a biotechnology company, discovers and develops drugs for the treatment of cancer. Its lead program is TNG908, a synthetic lethal small molecule inhibitor of protein ...

Omega Therapeutics Inc OMGA

4d ago, source: Morningstar

Morningstar Quantitative Ratings for Stocks are generated using an algorithm that compares companies that are not under analyst coverage to peer companies that do receive analyst-driven ratings ...

PFIZER INC's Net Worth

1mon ago, source: Benzinga.com

PFIZER INC has an estimated net worth of $2.44 Billion. This is based on reported shares across multiple companies, which include BioAtla, Inc., Viatris Inc, Cerevel Therapeutics Holdings, Inc ...

Cara Therapeutics Inc CARA

4d ago, source: Morningstar

Morningstar Quantitative Ratings for Stocks are generated using an algorithm that compares companies that are not under analyst coverage to peer companies that do receive analyst-driven ratings ...

Intellia Therapeutics, Inc.

5mon ago, source: CNN

Intellia Therapeutics, Inc. is a clinical stage genome editing company, which engages in the development of curative therapeutics using the CRISPR/Cas9 system. Its CRISPR/Cas9 system transforms ...

Seres Therapeutics Inc (MCRB) Reports Encouraging Sales Growth and Strategic Cost Savings in 2023

24d ago, source: Yahoo Finance

Warning! GuruFocus has detected 8 Warning Signs with MCRB. On March 5, 2024, Seres Therapeutics Inc (NASDAQ:MCRB) released its 8-K filing, announcing the fourth quarter and full year financial ...

Monopar Therapeutics Inc

3mon ago, source: CNN

Monopar Therapeutics, Inc. is a clinical stage biopharmaceutical company, which engages in developing proprietary therapeutics for cancer patients. It also focuses on building a drug development ...

Akero Therapeutics Inc (AKRO)

14d ago, source: Investing

Jonathan Young, the Chief Operating Officer of Akero Therapeutics, Inc. (NASDAQ:AKRO), has recently sold shares of the company's common stock, generating over $18,000 in the... Akero Therapeutics ...

Latest Neutral (free) Forecasts

STRONG BUY BUY NEUTRAL SELL STRONG SELL ALL

Loading the latest forecasts...

My Portfolio

Loading your portfolio...